COVID-19 Vaccine Found In The Hearts Of Dead People: Study Authored by Zachary Stieber via The Epoch Times (emphasis ours) COVID-19 vaccine...
When Sernova announced in June that five patients with type 1 diabetes with severe hyperglycemia and a complete inability to produce insulin were able...
Altesa BioSciences has raised a $35 million Series A from undisclosed investors, according to an SEC filing from July. The company develops antiviral drugs...
SAN DIEGO – Skye Bioscience, Inc. (OTCQB: SKYED), a pharmaceutical company developing drugs targeting the endocannabinoid system, initially through modulation...
Dr. Vanessa Bellat, an assistant professor of chemistry in radiology and an affiliate of the Molecular Imaging Innovations Institute (MI3) at Weill Cornell...
LAB eN2 will be based in Cambridge, MA, part of the Greater Boston region where Novo has anchored—and earlier this year announced plans to expand—its...
Yale University and Transcend Therapeutics, a rapid-acting psychedelic therapies developer, received a three-year collaborative grant from the U.S....
The Advanced Research Projects Agency for Health (ARPA-H) has awarded $45 million to rapidly develop sense-and-respond implant technology that could slash...
Novo Nordisk is now tapping into earlier stages of cardiometabolic research by bringing together academic institutions and German drug discovery shop Evotec...
It might appear as though the private biotech sector is approaching a thaw. In recent weeks, a Flagship startup raised $273 million, an RNA company put...
On September 25, 2023, Vaccitech (NASDAQ: VACC) experienced a jaw-dropping 90% surge in its stock price in just one day of trading. Now, this kind of...
By not disclosing milestone dollars that may or may never materialize, Exelixis showed Insilico Medicine CEO Alex Zhavoronkov, PhD, that its PR folks were...
Takeda is betting more than half a billion dollars on a California biotech’s approach to treating amyotrophic lateral sclerosis (ALS) and other neurodegenerative...
New York and Cambridge, UK — Recent research demonstrates that protein phase separation (PPS) is widely present in cells and drives a variety of important...
Jennifer Meade, Aldevron’s new president, has been elevated from general manager, nucleic acids, where she led strategic initiatives that included expanding...
Mark Velleca → David M. Epstein is out as CEO of cancer player Black Diamond Therapeutics, which is putting chairman Mark Velleca in charge. This is...
A team of biomedical engineers has developed a hydrogel-based delivery system that balances the acidic environment in a tumor and enhances the cancer-fighting...
The biotech licensing whizzes at Aditum Bio, the VC firm from ex-Novartis CEO Joe Jimenez and Mark Fishman, have created their 10th company by nabbing...
Every year, without fail, the Endpoints 11 proves to be the most challenging project I face — and definitely remains the most fun. In an industry...
Craniosynostosis, the premature fusion of the top of the skull in infants, is caused by an abnormal excess of a previously unknown type of bone-forming...
A research team led by scientists from City University of Hong Kong (CityU) has achieved a significant breakthrough by inventing a new class of near-infrared-activated...
NEW YORK, NY (September 20, 2023)—Columbia will award the 2023 Louisa Gross Horwitz Prize to Zhijian ‘James’ Chen and Glen Barber for discovering...
NightHawk Biosciences laid off 14% of its workforce in R&D in order to focus on its contract development and manufacturing organization (CDMO), just...
The race to develop new therapies that precisely edit short-lived RNA molecules instead of making irreversible changes to DNA is heating up. A new entrant...
Seeing the successes of other covalent medicines companies, a group of blue-chip investors is lining up to take the next shot on goal. RA Capital, typically...
Arialys is developing an antibody therapeutic, ART5803, to treat anti-NMDA receptor encephalitis (ANRE), one of the most common forms of autoimmune encephalitis....
PHILADELPHIA—(Sep. 18, 2023)—Zachary Schug, Ph.D., assistant professor in the Molecular and Cellular Oncogenesis Program of the Ellen and Ronald Caplan...
Reston, VA—A new 225Ac-DOTA-based pre-targeted radioimmunotherapy (PRIT) system has been shown to cure a highly lethal form of advanced intraperitoneal...
HOUSTON ― Researchers at The University of Texas MD Anderson Cancer Center have discovered that certain nano-based cancer therapies may be less effective...
TARRYTOWN, NY — For over three decades, Regeneron has been synonymous with one thing in the drug industry: antibodies. Blockbusters like Dupixent, Eylea,...